These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. N-demethylation of cocaine to norcocaine. Evidence for participation by cytochrome P-450 and FAD-containing monooxygenase. Kloss MW; Rosen GM; Rauckman EJ Mol Pharmacol; 1983 Mar; 23(2):482-5. PubMed ID: 6835204 [TBL] [Abstract][Full Text] [Related]
5. Effect of inhibitors of the FAD-containing monooxygenase system from rat liver microsomes on monomethylhydrazine metabolism and activation to reactive metabolites. Díaz Gómez MI; Castro JA Arch Toxicol; 1986 May; 59(1):64-6. PubMed ID: 3741147 [TBL] [Abstract][Full Text] [Related]
6. Stereospecificity in the oxidation of phorate and phorate sulphoxide by purified FAD-containing mono-oxygenase and cytochrome P-450 isozymes. Levi PE; Hodgson E Xenobiotica; 1988 Jan; 18(1):29-39. PubMed ID: 3354230 [TBL] [Abstract][Full Text] [Related]
7. Cocaine-induced hepatotoxicity: lipid peroxidation as a possible mechanism. Teaf CM; Freeman RW; Harbison RD Drug Chem Toxicol; 1984; 7(4):383-96. PubMed ID: 6489192 [TBL] [Abstract][Full Text] [Related]
8. Sulphoxidation of albendazole by the FAD-containing and cytochrome P-450 dependent mono-oxygenases from pig liver microsomes. el Amri HS; Fargetton X; Delatour P; Batt AM Xenobiotica; 1987 Oct; 17(10):1159-68. PubMed ID: 3424864 [TBL] [Abstract][Full Text] [Related]
9. The flavoprotein domain of P450BM-3: expression, purification, and properties of the flavin adenine dinucleotide- and flavin mononucleotide-binding subdomains. Sevrioukova I; Truan G; Peterson JA Biochemistry; 1996 Jun; 35(23):7528-35. PubMed ID: 8652532 [TBL] [Abstract][Full Text] [Related]
10. Acute cocaine-induced hepatotoxicity in DBA/2Ha male mice. Kloss MW; Rosen GM; Rauckman EJ Toxicol Appl Pharmacol; 1982 Aug; 65(1):75-83. PubMed ID: 7147258 [No Abstract] [Full Text] [Related]
11. Resistance of some phase II biotransformation pathways to hepatotoxins. Gregus Z; Watkins JB; Thompson TN; Klaassen CD J Pharmacol Exp Ther; 1982 Aug; 222(2):471-9. PubMed ID: 7097566 [No Abstract] [Full Text] [Related]
12. Regenerative changes in hepatic morphology and enhanced expression of CYP2B10 and CYP3A during daily administration of cocaine. Pellinen P; Stenbäck F; Kojo A; Honkakoski P; Gelboin HV; Pasanen M Hepatology; 1996 Mar; 23(3):515-23. PubMed ID: 8617431 [TBL] [Abstract][Full Text] [Related]
13. Cocaine N-demethylation and the metabolism-related hepatotoxicity can be prevented by cytochrome P450 3A inhibitors. Pellinen P; Honkakoski P; Stenbäck F; Niemitz M; Alhava E; Pelkonen O; Lang MA; Pasanen M Eur J Pharmacol; 1994 Jan; 270(1):35-43. PubMed ID: 8157080 [TBL] [Abstract][Full Text] [Related]
17. Is thiobenzamide a specific substrate for the microsomal FAD-containing monooxygenase? Levi PE; Tynes RE; Sabourin PJ; Hodgson E Biochem Biophys Res Commun; 1982 Aug; 107(4):1314-8. PubMed ID: 7138540 [No Abstract] [Full Text] [Related]
18. The role of benzoylmethylecgonine in cocaine-induced hepatotoxicity. Freeman RW; Harbison RD J Pharmacol Exp Ther; 1981 Aug; 218(2):558-67. PubMed ID: 7252855 [No Abstract] [Full Text] [Related]
19. Formation of flavin semiquinone during the reduction of P450 BM3 reductase domain with NADPH. Munro AW; Coggins JR; Lindsay JG; Daff S; Chapman SK Biochem Soc Trans; 1996 Feb; 24(1):18S. PubMed ID: 8674656 [No Abstract] [Full Text] [Related]
20. On the domain structure of cytochrome P450 102 (BM-3): isolation and properties of a 45-kDa FAD/NADP domain. Black SD Biochem Biophys Res Commun; 1994 Aug; 203(1):162-8. PubMed ID: 8074651 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]